COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1781: Articles 17801-17810  | Next

Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination
Gilbert, P. D., Rudnick, C. A.
10.1101/2021.02.03.21250579 — Posted: 2021-02-05 Discussion: Onsite
Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by 501Y.v2 (lineage B.1.351) in the Eastern Cape, South Africa
Laguda Akingba, O., Sprong, K., Hardie, D. R.
10.1101/2021.02.03.21251057 — Posted: 2021-02-05
Using a household structured branching process to analyse contact tracing in the SARS-CoV-2 pandemic
Fyles, M., Fearon, E., Overton, C., University of Manchester COVID-19 Working Group, , Wingfield, T., Medley, G. F., Hall, I., Pellis, L., House, T.
10.1101/2021.02.03.21250992 — Posted: 2021-02-05
Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England
Nafilyan, V., Islam, N., Mathur, R., Ayoubkhani, D., Banerjee, A., Glickman, M., Humberstone, B., DIamond, I., Khunti, K.
10.1101/2021.02.03.21251004 — Posted: 2021-02-05
How did COVID-19 measures impact sexual behaviour and access to STI&HIV services in Panama? Results from a national cross-sectional online survey
Gabster, A., Toller Erausquin, J., Michielsen, K., Mayaud, P., Pascale, J. M., Pericas Escale, C., Marks, M., Katz, J., Cabezas Talavero, G., de Argote, M., Murillo Estrada, A., Tucker, J. D.
10.1101/2021.02.03.21251095 — Posted: 2021-02-05
COVID19-related and all-cause mortality among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection in the region of Tarragona, Spain: results from the COVID19 TARRACO Cohort Study, March-June 2020.
Vila-corcoles, A., Satue-Gracia, E., Vila-Rovira, A., de Diego-Cabanes, C., Forcadell-Peris, M. J., Ochoa-Gondar, O.
10.1101/2021.02.02.21251028 — Posted: 2021-02-05
GPS-estimated foot traffic data and venue selection for COVID-19 serosurveillance studies
Brown, T. S., Martinez de Salazar Munoz, P., Bhatia, A., Bunda, B., Williams, E. K., Bor, D., Miller, J. S., Mohareb, A., Naranbai, V., Garcia Beltran, W., Miller, T. E., Thierauf, J., Yang, W., Kress, D., Stelljes, K., Johnson, K., Larremore, D. B., Lennerz, J., Iafrate, A. J., Balsari, S., Buckee, C. O., Grad, Y. H.
10.1101/2021.02.03.21251011 — Posted: 2021-02-05
COVID-19 infection and subsequent thromboembolism: A self-controlled case series analysis of a population cohort
Ho, F., Man, K., Toshner, M., Celis-Morales, C., Wong, I., Sattar, N., Pell, J.
10.1101/2021.02.02.21251043 — Posted: 2021-02-05
A Dynamic Bayesian Model for Identifying High-Mortality Risk in Hospitalized COVID-19 Patients
Momeni-Boroujeni, A., Mendoza, R., Stopard, I. J., Lambert, B., Zuretti, A.
10.1101/2021.02.02.21251023 — Posted: 2021-02-05
A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients with COVID-19
Qiao, R., Ko, J., Yang, W.
10.1101/2021.02.03.21251088 — Posted: 2021-02-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).